Of the 125 patients, 90 were diagnosed with BCP-ALL and showed a lower TK1 levels than patients with TCP-ALL or AML (range: 35–118 IU/L, 288–2108 IU/L, and 88–750 IU/L, respectively, p = 0.001). Here, TK1 is linked to acute lymphoblastic leukemia.